Fred Alba

Fred Alba, MD, MBA, currently serves as Director of U.S. Medical Marketing for IgG4-RD at Amgen, focusing on UPLIZNA in rare disease management, where responsibilities include P2P strategy, HCP education, KOL mapping, and conference strategy. Prior experience includes leading global engagement and portfolio maximization for AbbVie's gastroenterology division, directing rare diseases at Biogen, and managing integrated care portfolios at Sanofi. Additional roles encompassed market access strategy and customer marketing at Pfizer, alongside business unit management and medical advising at Quimiza. Fred holds an MBA from Universidad Privada de Santa Cruz de la Sierra and an MD from Universidad Autónoma Gabriel René Moreno.